Growth Metrics

BridgeBio Pharma (BBIO) Tax Provisions (2024 - 2025)

BridgeBio Pharma's Tax Provisions history spans 2 years, with the latest figure at -$120000.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 110.41% to -$120000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a N/A change, with the full-year FY2025 number at $435000.0, down 62.27% from a year prior.
  • Tax Provisions hit -$120000.0 in Q4 2025 for BridgeBio Pharma, up from -$1.5 million in the prior quarter.
  • Over the last five years, Tax Provisions for BBIO hit a ceiling of $2.1 million in Q2 2025 and a floor of -$1.5 million in Q3 2025.